Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
Specific Biologics has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Specific Biologics's investors include Creative Destruction Lab (CDL), Lumira Ventures, adMare Bio Innovations, Genome Canada, Ontario Genomics.
Specific Biologics is headquartered in Toronto, Canada.
Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
Specific Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Specific Biologics — Funding & Investors." VCBacked, March 18, 2026, https://www.vcbacked.co/company/specific-biologics. Accessed July 20, 2026.
VCBacked. (2026). Specific Biologics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/specific-biologics
{{cite web |title=Specific Biologics — Funding & Investors |url=https://www.vcbacked.co/company/specific-biologics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated